Press Releases

LOS ANGELES, Sept. 26, 2019 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) today announced a collaboration with Pfizer Global Medical Grants to fund approximately $2 million in research grants through a Competitive Research Grants Program, which  is focused on investigating talazoparib, a poly (ADP-ribose) polymerase (PARP) i

LONDON, Sept. 26, 2019 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology business, today announced the launch of its new INTERTAN Product Assurance (IPA) Program at the Orthopaedic Trauma Association Annual Meeting in Denver, CO. This first-of-its-kind program centers on the superior performance of the TRIGEN

ROCK HILL, S.C., Sept. 26, 2019 /PRNewswire/ -- 

ST. JOHN, Ind., Sept. 26, 2019 /PRNewswire/ -- Athletico Physical Therapy has opened a new location in St. John on Monday, September 23rd and is conveniently located just south of La Quesadilla Mexican Grill, Great Clips and Rosati's Pizza off of Wicker Ave (

CHICAGO, Sept. 26, 2019 /PRNewswire/ -- Sysmex America, Inc. and

THOUSAND OAKS, Calif., Sept. 26, 2019 /PRNewswire/ -- In recognition of World Heart Day on Sunday, September 29, Amgen (NASDAQ:AMGEN) today released findings from a global survey that evaluated worldwide heart attack survivors' perceptions and awareness of the connection between cholesterol and cardiovascular (CV) events.View the

Former CEO of Philips' Personal Health Business Will Now Help the Company Behind the Groundbreaking CPAP Cleaner Advance Its Mission to Improve the Lives of Sleep Apnea Sufferers in Europe and Asia PETERBOROUGH, N.H., Sept. 26, 2019 /PRNewswire/ -- 

NEW YORK, Sept. 26, 2019 /PRNewswire/ -- Flinders University in partnership with New York-based tech company Nanit, today announced findings from a new s

WASHINGTON, Sept. 26, 2019 /PRNewswire/ -- Fitbit and Apple Watch both excel in brand recognition in the wearable market, according to

MILAN, Sept. 26, 2019 /PRNewswire/ -- Newronika, a spin-off of world-class neurological research centers Policlinico of Milan and University of Milan, has raised an 8.4 million Euros Series-A round. The investment was led by French venture capital fund Omnes together with existing investors Innog